Statistics for EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients
Total visits
views | |
---|---|
EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients | 86 |
Total visits per month
views | |
---|---|
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
File Visits
views | |
---|---|
HillGallant_2020_EOS789.pdf | 197 |
java.util.UUID:d70bf34a-dad9-4bf3-8a78-70421026d985 | 82 |
java.util.UUID:389245e4-d77e-4416-8cf8-cda03c7aa3ae | 9 |
java.util.UUID:6f23f40a-ec15-4db4-8a54-084f786bef01 | 4 |
Top country views
views | |
---|---|
United States | 68 |
Canada | 3 |
Japan | 2 |
Germany | 1 |
United Kingdom | 1 |
Malaysia | 1 |
Russia | 1 |
Sweden | 1 |
Top city views
views | |
---|---|
Wilmington | 40 |
Fairfield | 8 |
Houston | 5 |
Toronto | 3 |
Cambridge | 2 |
Washington | 2 |
Baltimore | 1 |
Belvedere Tiburon | 1 |
Bloomington | 1 |
Chicago | 1 |
Jacksonville | 1 |
Kiez | 1 |
London | 1 |
Osaka | 1 |
Saint Petersburg | 1 |
Seattle | 1 |
Seremban | 1 |
Stockholm | 1 |